-+ 0.00%
-+ 0.00%
-+ 0.00%

Silexion Therapeutics Plans Private Placement for $2.5 Million in Net Proceeds

PUBT·11/19/2026 13:08:27
Silexion Therapeutics Plans Private Placement for $2.5 Million in Net Proceeds
  • Silexion Therapeutics must complete a planned private placement raising $2.5 million net by December 4, 2026, to retain its Nasdaq listing.
  • A Nasdaq panel granted conditional continued listing on November 18, 2026, requiring compliance with the $2.5 million minimum shareholders' equity requirement.
  • The company must maintain a closing bid of at least $1 for ten consecutive trading days by November 24, 2026.
  • A planned public offering must raise at least $5 million by March 31, 2027.
  • Compliance with all Nasdaq listing requirements must continue through May 15, 2027; new violations during that period will trigger immediate delisting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silexion Therapeutics Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-005294), on November 19, 2026, and is solely responsible for the information contained therein.